Martínez-Arias

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • People at high risk of STIs
  • Children (1-11 years)
  • Men who have sex with men
  • Primary care
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection

RECLAIM

The Netherlands
|
2025
  • Adults (18-64 years)
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immunomodulator
  • Colchicine
  • Metformin

SwissPrEPared

Switzerland
|
2019-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • PrEP users
  • Hospital wide
  • Community
  • Primary care
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Syphilis
  • Sexually transmitted infection
  • Pharmacological intervention
  • PrEP-bSTI

DanPrEPD

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Syphilis
  • Sexually transmitted infection
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

Bellmann-Strobl

Germany
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • vasodilator
  • Vericiguat

Faulkner

United Kingdom
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Physical activity

Santiago

Spain
|
2023-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Lifestyle intervention
  • Education
  • Therapeutic Exercise

MiLoCoDaS

Germany
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Digital health

LoCoKi

Germany
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • Telemedicine
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Telemedicine

ErgoLoCo

Germany
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

SIPCOV

Norway
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

BEACON

United Kingdom
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation